Exponent, Inc.EXPONASDAQ

|||

Switch Symbol:

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 71% recommend buying.

Consensus Rating

Buy

7 analysts·Limited coverage

71%

Rating Distribution

Strong Buy

00%

Buy

571%

Hold

229%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 16% higher.

Bear Case

$81.00

+16%

Consensus

$81.00

+16%

Bull Case

$81.00

+16%

Price Range7 analysts

Low

Consensus

High

$81.00

Current Target

Current Price

$69.92

Upside to Target

$11.08

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$2.06(4 analysts)

P/E36x

Current: 35.9x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+8.27%

EPS+9.31%

FY2028

Rev+8.50%

EPS+9.81%

Earnings Surprises

Beat rate:67%(8/12 quarters)

Avg surprise:+7.0%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Dec 15, 2025UBS

Exponent price target raised to $81 from $76 at UBS

Target:$81.00

+10.0%from $73.64

Jul 26, 2024Truist Financial

Exponent price target raised to $120 from $100 at Truist

Target:$120.00

+13.7%from $105.54

Jun 26, 2024UBS

UBS Reiterates Neutral Rating on Exponent (EXPO)

Target:$88.00

-6.8%from $94.44

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance